Curanex Pharmaceuticals Inc
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation NV
Business Address 2 JERICHO PLAZA,, JERICHO, NY, 11753
Mailing Address 2 JERICHO PLAZA,, JERICHO, NY, 11753
Phone 718-673-6078
Fiscal Year End 1231
EIN 830741390
Financial Overview
FY2025
-$362K
Net Income
$11.58M
Total Assets
$361K
Total Liabilities
$-0.03
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 8-K Current report of material events | January 5, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 17, 2025 | View on SEC |
| 8-K Current report of material events | November 6, 2025 | View on SEC |
| 8-K Current report of material events | September 29, 2025 | View on SEC |
| 8-K Current report of material events | September 12, 2025 | View on SEC |
| 10-Q Quarterly financial report | September 9, 2025 | View on SEC |
| 3 Initial insider ownership report | September 2, 2025 | View on SEC |
| 3 Initial insider ownership report | September 2, 2025 | View on SEC |
Annual Reports
10-K March 30, 2026
- Lead drug candidate Phyto-N successfully completed 28-day rodent safety studies.
- Successfully produced 50kg of Phyto-N pilot batch meeting strict FDA quality standards.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.